PubRank

E Lavi

Author PubWeight™ 88.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A 1987 4.98
2 Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome. J Virol 1988 2.46
3 Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992 2.41
4 Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996 2.33
5 Magnetic resonance imaging of Creutzfeldt-Jacob disease. Ann Neurol 1991 2.06
6 Latent herpes simplex virus type 1 transcription in human trigeminal ganglia. J Virol 1988 2.02
7 Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J Virol 1997 1.98
8 Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol 1999 1.86
9 A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease. J Virol 1994 1.65
10 Spinal dural arteriovenous fistula: the pathology of venous hypertensive myelopathy. Neurology 1995 1.64
11 Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 1984 1.64
12 Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1997 1.61
13 Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol 2000 1.55
14 Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol 2000 1.48
15 Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein. Virology 1997 1.46
16 MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology 1994 1.45
17 Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol 2001 1.43
18 Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 1998 1.39
19 Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol 1984 1.38
20 Hemangiopericytoma of the third ventricle. Case report. J Neurosurg 1999 1.37
21 Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 1986 1.31
22 The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res 1998 1.27
23 Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol 1998 1.24
24 The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol 1998 1.23
25 Dependence of apparent diffusion coefficients on axonal spacing, membrane permeability, and diffusion time in spinal cord white matter. J Magn Reson Imaging 1998 1.21
26 Mouse hepatitis virus type-2 infection in mice: an experimental model system of acute meningitis and hepatitis. Exp Mol Pathol 2001 1.15
27 Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J Virol 1993 1.14
28 The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci 1986 1.12
29 Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice. J Immunol 2001 1.11
30 Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J Neurovirol 2002 1.10
31 Epidural haemangiomas during pregnancy. J Neurol Neurosurg Psychiatry 1986 1.09
32 HIV-1 infection of cultured human adult oligodendrocytes. Virology 1996 1.00
33 Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice. J Virol 1990 0.99
34 Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis. J Neurovirol 2001 0.99
35 Ictal hemiparesis. Eur Neurol 1982 0.98
36 Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. Am J Pathol 1995 0.95
37 Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. J Immunol 1988 0.93
38 Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microb Pathog 1995 0.92
39 Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. J Neurovirol 2000 0.90
40 Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Mod Pathol 1996 0.90
41 CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J Neurovirol 1997 0.90
42 MHV-A59 pathogenesis in mice. Adv Exp Med Biol 1984 0.90
43 CXCR3 expression in human central nervous system diseases. Neuropathol Appl Neurobiol 2001 0.89
44 Late onset of isolated central nervous system metastasis of liposarcoma--a case report. Am J Clin Oncol 1996 0.88
45 Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively. Clin Immunol 2001 0.88
46 Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J Neuropathol Exp Neurol 2001 0.88
47 A mucin-like glycoprotein identified by MAG (mouse ascites Golgi) antibodies. Menstrual cycle-dependent localization in human endometrium. Am J Pathol 1995 0.87
48 Pathogenesis of cerebral infarction and hemorrhage induced by a murine leukemia virus. Lab Invest 1994 0.87
49 Primary pontine hemorrhage with complete recovery. Arch Neurol 1981 0.86
50 Infection of the basal ganglia by a murine coronavirus. Science 1985 0.85
51 Intracerebral hemorrhages and infarction induced by a murine leukemia virus is influenced by host determinants within endothelial cells. Virology 1994 0.84
52 Programmed cell death in MHV-induced demyelination. Adv Exp Med Biol 2001 0.84
53 Case of the month: March 1998--48 year old man with back pain and weakness. Brain Pathol 1998 0.84
54 HTLV-I infection of cerebrospinal fluid T cells from patients with chronic neurologic disease. AIDS Res Hum Retroviruses 1987 0.84
55 Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice. Clin Immunol 1999 0.83
56 Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. Blood 1997 0.83
57 Role of the spike protein in murine coronavirus induced hepatitis: an in vivo study using targeted RNA recombination. Adv Exp Med Biol 2001 0.83
58 Hepatitis mutants of mouse hepatitis virus strain A59. Adv Exp Med Biol 1995 0.83
59 Varicella-zoster ventriculo-encephalitis and spinal cord infarction in a patient with AIDS. Acta Neuropathol 1996 0.82
60 Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis. Clin Immunol 2000 0.82
61 Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. J Vet Pharmacol Ther 1998 0.81
62 Case of the month: May 1998--a patient with HIV infection and multiple cranial neuritis. Brain Pathol 1998 0.80
63 Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Curr Eye Res 2000 0.80
64 Experimental allergic neuritis in the SJL/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12. J Neuroimmunol 2000 0.79
65 Coronavirus MHV-A59 causes upregulation of interferon-beta RNA in primary glial cell cultures. Adv Exp Med Biol 1998 0.79
66 Protection of neonatal mice from fatal reovirus infection by immune serum and gut derived lymphocytes. Adv Exp Med Biol 1991 0.78
67 Prenatal diagnosis of thrombocytopenia absent radius syndrome by ultrasound and cordocentesis. Prenat Diagn 1990 0.78
68 Monoclonal antibody 2H1 detects a 60-65 KD membrane polypeptide of the rough endoplasmic reticulum of neurons and selectively stains cells of several rat tissues. J Histochem Cytochem 1991 0.78
69 Oligoclonal immunoglobulin bands in cerebrospinal fluid of a patient with lymphocytic choriomeningitis. Ann Neurol 1986 0.78
70 Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein. Adv Exp Med Biol 2001 0.77
71 Characterization of experimental spinal cord injury with magnetization transfer ratio histograms. J Magn Reson Imaging 2000 0.77
72 Transformation of a low-grade pineal parenchymal tumour to secondary pineoblastoma. Neuropathol Appl Neurobiol 2009 0.76
73 Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries. Atherosclerosis 2001 0.76
74 Differential expression of tumor necrosis factor in primary glial cell cultures infected with demyelinating and non-demyelinating MHVs. Adv Exp Med Biol 2001 0.76
75 Demyelination determinants in the S gene of MHV. Adv Exp Med Biol 2001 0.76
76 Endoscopic management of a rare case of nasal glioma in Meckel's cave in an adult: case report. Minim Invasive Neurosurg 2010 0.75
77 OlP-1, a novel protein that distinguishes early oligodendrocyte precursors. J Neurosci Res 1997 0.75
78 July 2000: A 70 year old with rigidity, decreased ocular movements, and dementia. Brain Pathol 2001 0.75
79 [The viral hypothesis of the etiology of multiple sclerosis]. Harefuah 1985 0.75
80 Pathogenesis of fusion deficient recombinant mouse hepatitis viruses. Adv Exp Med Biol 2001 0.75
81 Detection of lipoprotein(a) in intraparenchymal cerebral vessels: correlation with vascular pathology and clinical history. Exp Mol Pathol 2001 0.75
82 The C12 mutant of MHV-A59 is very weakly demyelinating and has five amino acid substitutions restricted to the spike and replicase genes. Adv Exp Med Biol 1998 0.75
83 Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline. J Neurol Sci 1996 0.75
84 Thrombotic microangiopathy isolated to the central nervous system. Ann Neurol 1991 0.75
85 [Beriberi--case report]. Harefuah 1981 0.75
86 Case of the month: April 1997--a 32 year old man with mental status changes and a severe occipital headache. Brain Pathol 1998 0.75
87 Foam Fractionation with Reflux. Science 1961 0.75
88 Effects of lipofuscin on in situ hybridization in human neuronal tissue. J Virol Methods 1989 0.75
89 An unsuspected sign of cutaneous allergy. J Am Acad Dermatol 1981 0.75
90 Detection of MHV-A59 RNA by in situ hybridization. Adv Exp Med Biol 1984 0.75
91 The role of B cells in mouse hepatitis virus infection and pathology. Adv Exp Med Biol 2001 0.75
92 The effect of the T1087N S gene mutation on MHV-A59 pathogenesis. Adv Exp Med Biol 2001 0.75